Tinlarebant

DB17832InvestigationalSmall molecule

Tinlarebant: Overview.

Chemical structure of Tinlarebant
Formula / weight
C21H21F5N4O2 · 456.417 g/mol (avg)
Also known as
1-(3-(4-(3,4-difluoro-2-(trifluoromethyl)phenyl)piperidine-1-carbonyl)-1h,4h,5h,6h,7h-pyrazolo(3,4-c)pyridin-6-yl)ethan-1-one · 1-(3-{4-[3,4-Difluoro-2-(Trifluoromethyl)Phenyl]Piperidine-1-Carbonyl}-1H,4H,5H,6H,7H-Pyrazolo[3,4-C]Pyridin-6-Yl)Ethan-1-One · Ethanone, 1-(3-((4-(3,4-difluoro-2-(trifluoromethyl)phenyl)-1-piperidinyl)carbonyl)-1,4,5,7-tetrahydro-6h-pyrazolo(3,4-c)pyridin-6-yl)
Code names
BPN-14967 · LBS-008

Resolves to

Compound
UNII63WI9S8P1MCAS1821327-95-0ChEMBLCHEMBL3967849
Structure
InChIKeyHAGSLCBZFRRBLS-UHFFFAOYSA-NSMILESCC(=O)N1CCC2=C(C1)NN=C2C(=O)N1CCC(CC1)C1=CC=C(F)C(F)=C1C(F)(F)F
Targets
P02753RBP4

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Tinlarebant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In